ARV-102, an oral therapy Arvinas is developing for people with Parkinson’s disease, was shown to reach the brain — where it is needed — and to be safe and well […] The post Parkinson’s therapy ARV-102 able to reach brain, where needed: Study appeared first on Parkinson's News Today.
